The abrdn Asia Pacific ex-Japan Equity Tracker costs as little as 0.07% a year. That’s an exceptionally low annual fee (OCF) for regional equity exposure. But two words in the name — “ex-Japan” — do more work than the price tag, and understanding them changes what you think you’re buying.
What’s actually in the fund
“Asia Pacific ex-Japan” sounds like it describes a geographic region. It does, but unevenly. Drop Japan and the remaining index weight concentrates fast. China and its related markets — including Hong Kong-listed shares — typically make up around a third to half of the index that these funds track. Add Australia, South Korea, Taiwan and India, and you’ve accounted for the large majority of your exposure. The rest of the region — Singapore, Indonesia, Malaysia, Thailand, the Philippines — fills in the remainder.
This matters because someone holding this tracker alongside a global index fund will find their China exposure is doing double-duty. Most global trackers already include China at its MSCI weighting. The Asia Pacific ex-Japan sleeve adds more on top of that. It’s not a mistake — it’s just worth knowing the overlap is there.
The fund itself is passive. abrdn is best known as an active house, and the brand carries that association. But this vehicle simply replicates an index; there’s no active stock selection here, no Asia specialists picking winners. That isn’t a criticism. A well-run tracker at 0.07%–0.11% is a straightforward, honest product. The point is to know what you’re buying before the label does the thinking for you.
Why the share class question matters
Four share classes of the same fund appear in the data block, and the differences are worth unpacking — because the wrong choice here costs you more than it should, for no extra exposure.
The two accumulation classes — N Acc and X Acc — automatically reinvest any dividends. The income-paying class — X Inc — pays dividends out to you in cash instead. The B Acc class is a third accumulation option. All four track the same index. All four carry the same total AUM of GBX 1.5bn.
The fee differences are small but real. X Acc and X Inc both charge 0.07%. N Acc charges 0.10%. B Acc charges 0.11%. On a £50,000 position, that’s a difference of roughly £20 a year between the cheapest and most expensive — not ruinous, but persistently compounding against you for identical exposure.
Same index, same manager, same AUM — and a four-basis-point fee gap that adds up over a decade.
The X classes carry institutional-tier labelling, which typically signals a minimum investment threshold or a distribution arrangement rather than a genuine product difference. If you’re checking your platform and the X Acc class appears alongside the B Acc, the underly ing fund is the same. What differs is the wrapper and, crucially, the annual charge you’ll pay for it.
For an investor who wants income — regular cash distributions from Asian dividends — the income-paying share class (X Inc) is the natural comparison. For one who wants compounding — dividends reinvested automatically — any of the accumulation classes serves, with the fee being the tiebreaker.
What to watch next
Three things are worth monitoring with this kind of regional tracker. First, shifts in China’s index weight — index providers have been reviewing the weighting of Chinese mainland shares (called A-shares) for some time, and any rebalancing changes your exposure without you doing anything. Second, currency: the fund is priced in sterling, but the underly ing assets are in Australian dollars, Hong Kong dollars, Korean won, Taiwanese dollars and Indian rupees, among others. When sterling strengthens, your returns take a haircut. And third, keep an eye on whether the share-class structure simplifies. Four classes of the same tracker is one more layer of complexity than most investors need. That’s the detail that catches people out most.
Past performance is not a guide to future returns. Capital is at risk.
Past performance is not a guide to future returns. Capital is at risk.
Funds Benchmark provides research and tooling for institutional and private investors. Nothing in this note is investment advice or a recommendation to buy or sell any specific fund.